NOVA:FRA
Novo Nordisk A/S
€36.90
arrow_upward
+1.60%(+0.58) 1ದಿನ
13 ನವೆಂ, 10:00:00 PM GMT+1 · EUR
search
ಎಲ್ಲಾ ಚಿಹ್ನೆಗಳು
| ಚಿಹ್ನೆ | ಬೆಲೆ | ಬದಲಾವಣೆ | % ಬದಲಾವಣೆ |
|---|
insights_autoNOVA ಗಾಗಿ ಉನ್ನತ ಒಳನೋಟಗಳನ್ನು ಜನರೇಟ್ ಮಾಡಲಾಗುತ್ತಿದೆ...
ತೆರೆಯಿರಿ
€36.42
ಅಧಿಕ
€37.34
ಕಡಿಮೆ
€36.42
ಮಾರ್ಕೆಟ್ ಕ್ಯಾಪ್
142.04ಬಿ
ಸರಾಸರಿ ಪ್ರಮಾಣ
655.00
ಪ್ರಮಾಣ
490.00
52 ವಾರದ ಗರಿಷ್ಠ
€54.80
52 ವಾರದ ಕನಿಷ್ಠ
€30.45
ಉದ್ಯೋಗಿಗಳ ಸಂಖ್ಯೆ
67ಸಾ
ತೆರೆಯಿರಿ
€36.42
ಅಧಿಕ
€37.34
ಕಡಿಮೆ
€36.42
ಮಾರ್ಕೆಟ್ ಕ್ಯಾಪ್
142.04ಬಿ
ಸರಾಸರಿ ಪ್ರಮಾಣ
655.00
ಪ್ರಮಾಣ
490.00
52 ವಾರದ ಗರಿಷ್ಠ
€54.80
52 ವಾರದ ಕನಿಷ್ಠ
€30.45
ಉದ್ಯೋಗಿಗಳ ಸಂಖ್ಯೆ
67ಸಾ
ಸುದ್ದಿ ಸ್ಟೋರಿಗಳು
ವೆಬ್ ಮೂಲಗಳು ಮತ್ತು ಸುದ್ದಿ ಪಾಲುದಾರರಿಂದ
The Motley Fool
·
4 ಗಂಟೆಗಳ ಹಿಂದೆ
Novo Nordisk vs. Pfizer: Does a Weight Loss or Cancer Focused Pharma Stock Make a Better Buy for 2027?
Traders Union
·
1 ದಿನದ ಹಿಂದೆ
Novo Nordisk stock rises over 2% as company pledges $200 million to World Diabetes Foundation and lifts guidance
Investing.com
·
2 ದಿನಗಳ ಹಿಂದೆ
Novo Nordisk partners with DJ Khaled for Wegovy campaign
The Motley Fool
·
2 ದಿನಗಳ ಹಿಂದೆ
JPMorgan Predicted Strong Wegovy Pill Sales (and Was Right). Is Novo Nordisk Stock a Buy Now?
ಪ್ರೊಫೈಲ್
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily obesity and diabetes medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 69,500 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. In 2023, Novo's market capitalization exceeded the GDP of Denmark, and it became the highest valued company in Europe. Wikipedia
Novo Nordisk A/S ಕುರಿತು
CEOಮೈಕ್ ಡೌಸ್ಟರ್
ಉದ್ಯೋಗಿಗಳು66.7ಸಾ
ಸ್ಥಾಪನೆ1923
ಪ್ರಧಾನ ಕಚೇರಿBagsværd, ಡೆನ್ಮಾರ್ಕ್ನ ರಾಜಧಾನಿ ಪ್ರದೇಶ, ಡೆನ್ಮಾರ್ಕ್
ವಲಯHealth Care
ಉದ್ಯಮ-
ವೆಬ್‌ಸೈಟ್novonordisk.com